Anti-AMBN/ AI1F functional antibody

Anti-AMBN/ AI1F functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to AMBN/AMBN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0658-Ab-1/ GM-Tg-hg-SE0658-Ab-2Anti-Human AMBN monoclonal antibodyHuman
GM-Tg-rg-SE0658-Ab-1/ GM-Tg-rg-SE0658-Ab-2Anti-Rat AMBN monoclonal antibodyRat
GM-Tg-mg-SE0658-Ab-1/ GM-Tg-mg-SE0658-Ab-2Anti-Mouse AMBN monoclonal antibodyMouse
GM-Tg-cynog-SE0658-Ab-1/ GM-Tg-cynog-SE0658-Ab-2Anti-Cynomolgus/ Rhesus macaque AMBN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0658-Ab-1/ GM-Tg-felg-SE0658-Ab-2Anti-Feline AMBN monoclonal antibodyFeline
GM-Tg-cang-SE0658-Ab-1/ GM-Tg-cang-SE0658-Ab-2Anti-Canine AMBN monoclonal antibodyCanine
GM-Tg-bovg-SE0658-Ab-1/ GM-Tg-bovg-SE0658-Ab-2Anti-Bovine AMBN monoclonal antibodyBovine
GM-Tg-equg-SE0658-Ab-1/ GM-Tg-equg-SE0658-Ab-2Anti-Equine AMBN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0658-Ab-1/ GM-Tg-hg-SE0658-Ab-2; GM-Tg-rg-SE0658-Ab-1/ GM-Tg-rg-SE0658-Ab-2;
GM-Tg-mg-SE0658-Ab-1/ GM-Tg-mg-SE0658-Ab-2; GM-Tg-cynog-SE0658-Ab-1/ GM-Tg-cynog-SE0658-Ab-2;
GM-Tg-felg-SE0658-Ab-1/ GM-Tg-felg-SE0658-Ab-2; GM-Tg-cang-SE0658-Ab-1/ GM-Tg-cang-SE0658-Ab-2;
GM-Tg-bovg-SE0658-Ab-1/ GM-Tg-bovg-SE0658-Ab-2; GM-Tg-equg-SE0658-Ab-1/ GM-Tg-equg-SE0658-Ab-2
Products NameAnti-AMBN monoclonal antibody
Formatmab
Target NameAMBN
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-AMBN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0658-Ag-1Recombinant multi-species AMBN/ AI1F protein
    ORF Viral VectorpGMLP001297human AMBN Lentivirus plasmid
    ORF Viral VectorvGMLP001297human AMBN Lentivirus particle


    Target information

    Target IDGM-SE0658
    Target NameAMBN
    Gene ID258,11698,25376,706845,482185,101096807,280995,100054155
    Gene Symbol and SynonymsAI1F,AMBN
    Uniprot AccessionQ9NP70,Q62840,Q9XSX7
    Uniprot Entry NameAMBN_HUMAN,AMBN_RAT,AMBN_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000178522
    Target ClassificationN/A

    The target: AMBN, gene name: AMBN, also named as AI1F. This gene encodes the nonamelogenin enamel matrix protein ameloblastin. The encoded protein may be important in enamel matrix formation and mineralization. This gene is located in the calcium-binding phosphoprotein gene cluster on chromosome 4. Mutations in this gene may be associated with dentinogenesis imperfect and autosomal dominant amylogenesis imperfect. [provided by RefSeq, Aug 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.